JASMINE RODRIGUEZ: Open Payments
NPI 1245749381 · WYOMISSING, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,092 in 112 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $1,209 · 2025 $3,092
Food & beverage: $3,092
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 19 | $711 |
| Madrigal Pharmaceuticals | 10 | $475 |
| ABBVIE INC. | 23 | $382 |
| PFIZER INC. | 15 | $295 |
| Ardelyx, Inc. | 7 | $286 |
| GENZYME CORPORATION | 6 | $219 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $216 |
| Gilead Sciences, Inc. | 4 | $172 |
| Regeneron Healthcare Solutions, Inc. | 5 | $90 |
| Ipsen Biopharmaceuticals, Inc | 2 | $44 |
Products named: TREMFYA, REZDIFFRA, DUPIXENT, IBSRELA, VELSIPITY, ENTYVIO, CREON, Livdelzi.
Industry payments across PA — which companies pay providers there.
